| Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines CY Liang, S Raju, Z Liu, Y Li, G Asthagiri Arunkumar, JB Case, ... Nature, 1-3, 2024 | 4 | 2024 |
| Computationally restoring the potency of a clinical antibody against Omicron TA Desautels, KT Arrildt, AT Zemla, EY Lau, F Zhu, D Ricci, S Cronin, ... Nature, 1-8, 2024 | | 2024 |
| Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds EC Wamhoff, L Ronsard, J Feldman, GA Knappe, BM Hauser, A Romanov, ... Nature communications 15 (1), 795, 2024 | 18 | 2024 |
| Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting CY Liang, S Raju, Z Liu, Y Li, GA Arunkumar, JB Case, SJ Zost, ... bioRxiv, 2024.01. 03.574018, 2024 | 1 | 2024 |
| Mucosal adenoviral-vectored vaccine boosting durably prevents XBB. 1.16 Infection in Nonhuman Primates M Gagne, BJ Flynn, SF Andrew, DR Flebbe, A Mychalowych, E Lamb, ... BioRxiv, 2023.11. 06.565765, 2023 | 4 | 2023 |
| Characterization of the SARS-CoV-2 BA. 5.5 and BQ. 1.1 Omicron variants in mice and hamsters JB Case, SM Scheaffer, TL Darling, TL Bricker, LJ Adams, HH Harastani, ... Journal of virology 97 (9), e00628-23, 2023 | 3 | 2023 |
| Neutralization, effector function and immune imprinting of Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Nature 621 (7979), 592-601, 2023 | 56 | 2023 |
| SARS-COV-2 inhibitors CAO Longxing, B Coventry, I Goreshnik, L Miller, D Baker, L Kozodoy, ... US Patent App. 18/004,545, 2023 | | 2023 |
| A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins V Chonira, YD Kwon, J Gorman, JB Case, Z Ku, R Simeon, RG Casner, ... Nature chemical biology 19 (3), 284-291, 2023 | 14 | 2023 |
| Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Biorxiv, 2023.01. 17.523798, 2023 | 23 | 2023 |
| Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants TA Desautels, KT Arrildt, AT Zemla, EY Lau, F Zhu, D Ricci, S Cronin, ... bioRxiv, 2022 | 3 | 2022 |
| The translational landscape of SARS-CoV-2-infected cells reveals suppression of innate immune genes M Puray-Chavez, N Lee, K Tenneti, Y Wang, HR Vuong, Y Liu, A Horani, ... MBio 13 (3), e00815-22, 2022 | 18 | 2022 |
| An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer N Suryadevara, AR Shiakolas, LA VanBlargan, E Binshtein, RE Chen, ... The Journal of Clinical Investigation 132 (11), 2022 | 19 | 2022 |
| Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies S Miersch, N Sharma, R Saberianfar, C Chen, F Caccuri, A Zani, ... Cell Reports 39 (9), 2022 | 8 | 2022 |
| Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice B Ying, SM Scheaffer, B Whitener, CY Liang, O Dmytrenko, S Mackin, ... Cell 185 (9), 1572-1587. e11, 2022 | 71 | 2022 |
| Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice AC Hunt, JB Case, YJ Park, L Cao, K Wu, AC Walls, Z Liu, JE Bowen, ... Science translational medicine 14 (646), eabn1252, 2022 | 77 | 2022 |
| SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters PJ Halfmann, S Iida, K Iwatsuki-Horimoto, T Maemura, M Kiso, ... Nature 603 (7902), 687-692, 2022 | 521 | 2022 |
| Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting BM Hauser, M Sangesland, KJS Denis, EC Lam, JB Case, IW Windsor, ... Cell Reports 38 (12), 2022 | 21 | 2022 |
| Targeting the fusion process of SARS-CoV-2 infection by small molecule inhibitors SB Park, P Irvin, Z Hu, M Khan, X Hu, Q Zeng, C Chen, M Xu, M Leek, ... MBio 13 (1), e03238-21, 2022 | 11 | 2022 |
| JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis J Son, S Huang, Q Zeng, TL Bricker, JB Case, J Zhou, R Zang, Z Liu, ... MBio 13 (1), e03377-21, 2022 | 20* | 2022 |
